Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Milton S. Hershey Medical Center
Memorial Sloan Kettering Cancer Center
University of Michigan Rogel Cancer Center
National Institutes of Health Clinical Center (CC)
Bambino Gesù Hospital and Research Institute
Thomas Jefferson University
University of Nebraska
Dana-Farber Cancer Institute
University of California, San Diego
Assistance Publique - Hôpitaux de Paris
Massachusetts General Hospital
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Instituto Nacional de Cancer, Brazil
St. Petersburg State Pavlov Medical University
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Beijing 302 Hospital
City of Hope Medical Center
University of Nebraska
Wake Forest University Health Sciences
University of Nebraska
Melbourne Health
First Affiliated Hospital of Zhejiang University
University of Liege
Kiadis Pharma
National Research Center for Hematology, Russia
H. Lee Moffitt Cancer Center and Research Institute
Lund University Hospital
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
University of Maryland, Baltimore
Children's Oncology Group
Hospital Israelita Albert Einstein
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
Hospital Israelita Albert Einstein
Thomas Jefferson University
University of Rochester
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Mesoblast, Ltd.